Selecta Biosciences
Latest round
- Series E
Last raised
- Sep 2015
Total raised
- $123M
Investors
- 10
About Selecta Biosciences
Selecta Biosciences, Inc.Selecta Biosciences, Inc. is a biotechnology firm founded in 2008 and based in Watertown, US. The company specializes in developing mRNA-based therapies for autoimmune conditions. Its founder, Omid Farokhzad, previously established other ventures.Selecta Biosciences specializes in mRNA therapies designed to treat autoimmune diseases, leveraging a proprietary platform for direct delivery of therapeutic proteins to patient cells.Selecta Biosciences aims to launch new mRNA-based products targeting autoimmune diseases and is actively pursuing expansion into additional markets within North America and Europe by the end of 2025.
Who invested in Selecta Biosciences
10 investors across 6 rounds
See all investors in Selecta Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Selecta Biosciences
Who invested in Selecta Biosciences?
Selecta Biosciences has 10 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Selecta Biosciences raised?
Selecta Biosciences has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Selecta Biosciences last raise money?
Selecta Biosciences's most recent round on record is a Series E, in Sep 2015.
What does Selecta Biosciences do?
Selecta Biosciences is a biotechnology company.
Where is Selecta Biosciences headquartered?
Selecta Biosciences is headquartered in Watertown, US.
Which VCs invest in companies like Selecta Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Selecta Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Selecta Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.